HOP André Mignot

Le Chesnay 78157

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hemorrhage, Hypertension, Leukemia, Myeloid, Acute

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed